IDENIX PHARMACEUTICALS INC·4

Nov 24, 4:42 PM ET

Weidenbruch John 4

4 · IDENIX PHARMACEUTICALS INC · Filed Nov 24, 2009

Insider Transaction Report

Form 4
Period: 2009-11-24
Weidenbruch John
Ex. VP, Gen. Counsel and Secr.
Transactions
  • Purchase

    Common Stock

    2009-11-24$1.89/sh+20,000$37,80035,000 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $1.92, inclusive. The reporting person undertakes to provide to Idenix Pharmaceuticals, any security holder of Idenix Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION